Education
About Us
Working with TipRanks
Follow Us
SIXL - ETF AI Analysis
Top Page
ETC 6 Meridian Low Beta Equity ETF (SIXL)
Rating:70Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several top holdings, such as Protagonist Therapeutics and InterDigital, have delivered strong year-to-date performance, supporting the ETF's potential growth.
Sector Diversification
The ETF is spread across multiple sectors, including Utilities, Consumer Defensive, and Health Care, reducing reliance on any single industry.
Moderate Expense Ratio
The fund's expense ratio is reasonable compared to actively managed ETFs, helping investors retain more of their returns.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, with over 99% exposure, limiting diversification across global markets.
Mixed Performance
While some holdings have performed well, others like MDU Resources Group and NextEra Energy have shown weaker year-to-date results, dragging overall returns.
Low Recent Returns
The ETF has delivered modest or negative performance over the year-to-date and three-month periods, which may concern investors seeking stronger short-term gains.
SIXL vs. SPDR S&P 500 ETF (SPY)
AUM190.95M
RegionNorth America
Expense Ratio0.47%
Beta0.35
IssuerMeridian
Inception DateMay 11, 2020
Dividend Yield2.11%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume7,624
30 Day Avg. Volume5,723
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
42.32Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering242
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SIXL Summary
The ETC 6 Meridian Low Beta Equity ETF (SIXL) is designed for investors who want steady returns with less risk. It focuses on companies that are less sensitive to market ups and downs, offering a mix of stocks across various sectors like utilities, healthcare, and consumer defensive. Some of its top holdings include well-known companies like NextEra Energy and Electronic Arts. This ETF is a good choice for those looking for stability and diversification in their portfolio. However, new investors should know that while it aims to reduce volatility, it can still be affected by overall market trends.
How much will it cost me?The ETC 6 Meridian Low Beta Equity ETF (Ticker: SIXL) has an expense ratio of 0.47%, meaning you’ll pay $4.70 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on selecting low beta stocks to reduce market volatility. This strategy requires more research and management compared to passively managed funds.
What would affect this ETF?The SIXL ETF, with its focus on low beta equities and strong exposure to sectors like Utilities, Consumer Defensive, and Health Care, could benefit from economic stability or increased demand for defensive stocks during market uncertainty. However, it may face challenges if interest rates rise, as sectors like Real Estate and Utilities are sensitive to borrowing costs, or if growth-oriented sectors like Technology underperform. Its U.S.-centric exposure also ties its performance closely to domestic economic conditions and regulatory changes.
SIXL Top 10 Holdings
The SIXL ETF leans heavily into defensive sectors like Utilities, Consumer Defensive, and Health Care, which together form the backbone of its low-volatility strategy. Coca-Cola Bottling is a steady performer, adding fizz to the fund’s returns, while United Therapeutics and Collegium Pharmaceutical are rising stars in the Health Care space, bolstered by strong earnings and growth momentum. On the flip side, Madison Square Garden Sports is lagging, weighed down by financial struggles and mixed technical signals. With its U.S.-focused portfolio and emphasis on stability, this ETF offers a calm harbor in choppy markets.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Dynavax | 0.63% | $1.21M | $1.81B | 18.31% | 70 Outperform | |
| Protagonist Therapeutics | 0.61% | $1.16M | $5.55B | 127.87% | 68 Neutral | |
| Dycom | 0.58% | $1.11M | $10.07B | 98.45% | 80 Outperform | |
| Coca-Cola Bottling Co Consolidated | 0.56% | $1.06M | $13.73B | 30.34% | 72 Outperform | |
| Madison Square Garden Sports | 0.55% | $1.05M | $6.26B | 17.63% | 45 Neutral | |
| Collegium Pharmaceutical | 0.54% | $1.02M | $1.58B | 71.21% | 71 Outperform | |
| United Therapeutics | 0.53% | $1.02M | $21.84B | 40.89% | 79 Outperform | |
| Royal Gold | 0.52% | $999.11K | $19.69B | 74.34% | 78 Outperform | |
| Ormat Techno | 0.52% | $994.68K | $6.86B | 66.31% | 71 Outperform | |
| CNX Resources | 0.52% | $991.33K | $4.94B | -0.03% | 64 Neutral |
SIXL Technical Analysis
Positive
―
Price Trends
36.65
Positive
36.65
Positive
36.40
Positive
Market Momentum
0.15
Negative
57.03
Neutral
69.44
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SIXL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.93, equal to the 50-day MA of 36.65, and equal to the 200-day MA of 36.40, indicating a bullish trend. The MACD of 0.15 indicates Negative momentum. The RSI at 57.03 is Neutral, neither overbought nor oversold. The STOCH value of 69.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SIXL.
SIXL Peer Comparison
Comparison Results
Performance Comparison
SIXL
ETC 6 Meridian Low Beta Equity ETF
37.18
0.82
2.26%
PLDR
Putnam Sustainable Leaders ETF
―
―
―
SYLD
Cambria Shareholder Yield ETF
―
―
―
ABFL
Fcf Us Quality Etf
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
EBI
Longview Advantage ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents